In this report, we have included: 1) a detailed clinical course, 2) radiological findings, 3) the surgical approach and its results, 4) pathological details, 5) marker expression analysis of tumor cells derived from the CD133-positive cells, and 6) evidence for ex vivo and in vivo behavior including tumor-initiating capacity. The gene discussed is PROM1; the disease is neoplasm.